aminocaproic acid

Generic: aminocaproic acid

Labeler: vitruvias therapeutics
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name aminocaproic acid
Generic Name aminocaproic acid
Labeler vitruvias therapeutics
Dosage Form TABLET
Routes
ORAL
Active Ingredients

aminocaproic acid 500 mg/1

Manufacturer
Vitruvias Therapeutics

Identifiers & Regulatory

Product NDC 69680-115
Product ID 69680-115_236ce9f5-3f2f-438f-a82d-04fc57314bf7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209060
Listing Expiration 2026-12-31
Marketing Start 2018-12-03

Pharmacologic Class

Established (EPC)
antifibrinolytic agent [epc]
Physiologic Effect
decreased fibrinolysis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69680115
Hyphenated Format 69680-115

Supplemental Identifiers

RxCUI
197351 476271
UPC
0369680116303 0369680115306
UNII
U6F3787206
NUI
N0000175634 N0000175632

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aminocaproic acid (source: ndc)
Generic Name aminocaproic acid (source: ndc)
Application Number ANDA209060 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (69680-115-00)
  • 30 TABLET in 1 BOTTLE (69680-115-30)
source: ndc

Packages (2)

Ingredients (1)

aminocaproic acid (500 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "236ce9f5-3f2f-438f-a82d-04fc57314bf7", "openfda": {"nui": ["N0000175634", "N0000175632"], "upc": ["0369680116303", "0369680115306"], "unii": ["U6F3787206"], "rxcui": ["197351", "476271"], "spl_set_id": ["555a0910-dbeb-4643-8b3a-c9fe9b803b3c"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "manufacturer_name": ["Vitruvias Therapeutics"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69680-115-00)", "package_ndc": "69680-115-00", "marketing_start_date": "20181203"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (69680-115-30)", "package_ndc": "69680-115-30", "marketing_start_date": "20181203"}], "brand_name": "Aminocaproic Acid", "product_id": "69680-115_236ce9f5-3f2f-438f-a82d-04fc57314bf7", "dosage_form": "TABLET", "pharm_class": ["Antifibrinolytic Agent [EPC]", "Decreased Fibrinolysis [PE]"], "product_ndc": "69680-115", "generic_name": "Aminocaproic Acid", "labeler_name": "Vitruvias Therapeutics", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aminocaproic Acid", "active_ingredients": [{"name": "AMINOCAPROIC ACID", "strength": "500 mg/1"}], "application_number": "ANDA209060", "marketing_category": "ANDA", "marketing_start_date": "20181203", "listing_expiration_date": "20261231"}